RPRX
Royalty Pharma plc$49.63-0.01 (-0.02%)Prev Close$49.65·MCap$21.20B·P/E27.79·Vol999.4K·Yield0.02%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
21
$51.26M
◆
Net Activity
Net Seller
$51.26M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Royalty Pharma plc (RPRX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 21 insider sales totaling $51.26M. The most recent insider transaction was by Coyne Terrance P. (EVP & CFO), who sold $10.36M worth of shares on Feb 2, 2026. Royalty Pharma plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $21.20B.
RPRX Insider Trading Activity
RPRX Insider Buying Activity
The following table shows recent insider purchases of Royalty Pharma plc (RPRX) stock reported via SEC Form 4 filings.
No insider buying activity found for RPRX in the last 12 months.
RPRX Insider Selling Activity
The following table shows recent insider sales of Royalty Pharma plc (RPRX) stock reported via SEC Form 4 filings.